BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37193301)

  • 1. Declined Humoral Immunity of Kidney Transplant Recipients to SARS-CoV-2 Vaccines.
    Mahallawi WH; Alharbi WA; Aloufi SA; Ibrahim NA; Abdelrahman MM; Alhomayeed BA; Aboonq MS; Alqahtani SAM; Rajih ES; Bakhsh AM; Sandokji I
    Infect Drug Resist; 2023; 16():2829-2840. PubMed ID: 37193301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.
    Ohki Y; Kawabe M; Yamamoto I; Katsumata H; Nakada Y; Kobayashi A; Urabe F; Miki J; Yamada H; Kimura T; Matsuo N; Tanno Y; Horino T; Ohkido I; Yamamoto H; Yokoo T
    Front Microbiol; 2022; 13():922042. PubMed ID: 35756063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
    Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
    Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients.
    Zhang L; Yang J; Lai C; Wan L; Xiong S; Kong W; Liu Z; Yu P; Chen M; Mai W; Khan SA; Deng M; Chen L; Lei Y; Zhou Q; Yu N; Li P; Chen Z; Ji T
    Front Immunol; 2022; 13():1042784. PubMed ID: 36700230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients.
    Seija M; García-Luna J; Rammauro F; Brugnini A; Trías N; Astesiano R; Santiago J; Orihuela N; Zulberti C; Machado D; Recalde C; Yandián F; Guerisoli A; Noboa J; Orihuela S; Curi L; Bugstaller E; Noboa O; Nin M; Bianchi S; Tiscornia A; Lens D
    Front Immunol; 2023; 14():1202630. PubMed ID: 37942335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
    Kolb T; Fischer S; Müller L; Lübke N; Hillebrandt J; Andrée M; Schmitz M; Schmidt C; Küçükköylü S; Koster L; Kittel M; Weiland L; Dreyling KW; Hetzel G; Adams O; Schaal H; Ivens K; Rump LC; Timm J; Stegbauer J
    Kidney360; 2021 Sep; 2(9):1491-1498. PubMed ID: 35373105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients.
    Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
    Front Immunol; 2022; 13():1050211. PubMed ID: 36532067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India.
    Jasuja S; Jha V; Sagar G; Bahl A; Verma S; Jasuja N; Kaur J
    Clin Kidney J; 2022 Jul; 15(7):1312-1321. PubMed ID: 35747093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.
    Kantauskaite M; Müller L; Kolb T; Fischer S; Hillebrandt J; Ivens K; Andree M; Luedde T; Orth HM; Adams O; Schaal H; Schmidt C; Königshausen E; Rump LC; Timm J; Stegbauer J
    Am J Transplant; 2022 Feb; 22(2):634-639. PubMed ID: 34551181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients.
    Körber N; Holzmann-Littig C; Wilkens G; Liao BH; Werz ML; Platen L; Cheng CC; Tellenbach M; Kappler V; Lehner V; Mijočević H; Christa C; Assfalg V; Heemann U; Schmaderer C; Protzer U; Braunisch MC; Bauer T; Renders L
    Front Immunol; 2023; 14():1172477. PubMed ID: 37063863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
    Kho MML; Messchendorp AL; Frölke SC; Imhof C; Koomen VJ; Malahe SRK; Vart P; Geers D; de Vries RD; GeurtsvanKessel CH; Baan CC; van der Molen RG; Diavatopoulos DA; Remmerswaal EBM; van Baarle D; van Binnendijk R; den Hartog G; de Vries APJ; Gansevoort RT; Bemelman FJ; Reinders MEJ; Sanders JF; Hilbrands LB;
    Lancet Infect Dis; 2023 Mar; 23(3):307-319. PubMed ID: 36354032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination.
    Zhang L; Yang J; Deng M; Xu C; Lai C; Deng X; Wang Y; Zhou Q; Liu Y; Wan L; Li P; Fang J; Hou J; Lai X; Ma F; Li N; Li G; Kong W; Zhang W; Li J; Cao M; Feng L; Chen Z; Chen L; Ji T
    Sci Rep; 2023 May; 13(1):7263. PubMed ID: 37142713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study.
    Yahav D; Rahamimov R; Mashraki T; Ben-Dor N; Steinmetz T; Agur T; Zingerman B; Herman-Edelstein M; Lichtenberg S; Ben-Zvi H; Bar-Haim E; Cohen H; Rotem S; Elia U; Margalit I; Zvi BR
    Transpl Int; 2022; 35():10204. PubMed ID: 35529596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination.
    Al Jurdi A; Gassen RB; Borges TJ; Solhjou Z; Hullekes FE; Lape IT; Efe O; Alghamdi A; Patel P; Choi JY; Mohammed MT; Bohan B; Pattanayak V; Rosales I; Cravedi P; Kotton CN; Azzi JR; Riella LV
    Front Immunol; 2022; 13():838985. PubMed ID: 35281011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.
    Chavarot N; Morel A; Leruez-Ville M; Vilain E; Divard G; Burger C; Serris A; Sberro-Soussan R; Martinez F; Amrouche L; Bererhi L; Lanternier F; Legendre C; Zuber J; Anglicheau D; Scemla A
    Am J Transplant; 2021 Dec; 21(12):4043-4051. PubMed ID: 34431207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study.
    Hovd M; Åsberg A; Munthe LA; Heldal K; Reisæter AV; Vaage JT; Lund-Johansen F; Midtvedt K
    EClinicalMedicine; 2023 Jun; 60():102035. PubMed ID: 37362086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose.
    Kühn T; Speer C; Morath C; Bartenschlager M; Kim H; Beimler J; Buylaert M; Nusshag C; Kälble F; Reineke M; Töllner M; Klein K; Blank A; Parthé S; Schnitzler P; Zeier M; Süsal C; Bartenschlager R; Tran TH; Schaier M; Benning L
    Transplantation; 2023 May; 107(5):1139-1150. PubMed ID: 36617671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Humoral Immune Response to BNT162b2 Vaccine Is Associated With Circulating CD19+ B Lymphocytes and the Naïve CD45RA to Memory CD45RO CD4+ T Helper Cells Ratio in Hemodialysis Patients and Kidney Transplant Recipients.
    Duni A; Markopoulos GS; Mallioras I; Pappas H; Pappas E; Koutlas V; Tzalavra E; Baxevanos G; Priska S; Gartzonika K; Mitsis M; Dounousi E
    Front Immunol; 2021; 12():760249. PubMed ID: 34925330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Vaccine-Induced T-Cell Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Kidney Transplant Recipients.
    Tometten I; Landmann S; Kantauskaite M; Lamberti J; Hillebrandt J; Müller L; Kittel M; Kolb T; Ivens K; Schmitz M; Voges A; Adams O; Andrée M; Schaal H; Lübke N; Königshausen E; Rump LC; Stegbauer J; Timm J
    J Infect Dis; 2023 Mar; 227(5):641-650. PubMed ID: 36408631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.